Physician profile
Leon W Lewis
NPI 1740260744
$3,166.08
in general payments reported to CMS, 2019-2025
22 companies · $1,824 in 2025
The $1,824 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $114 · 2021: $215 · 2022: $383 · 2023: $93.59 · 2024: $137 · 2025: $1,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,327 · Food and Beverage: $396 · Education: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,326.93 |
| Food and Beverage | $395.52 |
| Education | $331.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,722.34 | 2020-2025 | |
| Abbvie INC. | $421.30 | 2019-2025 | |
| Hologic Sales and Service, LLC | $167.97 | 2021-2022 | |
| Roche Diagnostics Corporation | $165.74 | 2019-2021 | |
| Organon LLC | $107.79 | 2022-2025 | Jada System |
| Amag Pharmaceuticals, INC. | $76.49 | 2019-2020 | |
| Exeltis, USA INC. | $72.81 | 2020-2022 | |
| Shield Therapeutics INC | $68.08 | 2022-2025 | Accrufer |
| Sumitomo Pharma America, INC. | $61.85 | 2023-2025 | Myfembree |
| Daiichi Sankyo INC. | $42.36 | 2020-2022 | |
| Mylan Pharmaceuticals INC. | $41.62 | 2019-2022 | |
| Baxter Healthcare | $39.46 | 2024 | Perclot, Seprafilm |
| Minerva Surgical, INC | $27.39 | 2019 | |
| Medtronic, INC. | $27.02 | 2025 | Plasmablade(Tm) |
| Convatec INC. | $18.47 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $17.71 | 2020 | |
| Coopersurgical, INC. | $17.27 | 2023 | Summit Doppler |
| Sobi, INC | $16.09 | 2019 | |
| Evofem Biosciences, INC. | $14.91 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.50 | 2023 | |
| Smith+Nephew, INC. | $13.51 | 2022 | |
| Mayne Pharma Commercial LLC | $11.40 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.